字号·· | 护眼
CNBC

周一华尔街重磅分析师观点汇总:英伟达、SpaceX、CoreWeave、特斯拉、Viking、纽柯、礼来等Here are Monday's biggest analyst calls: Nvidia, SpaceX, CoreWeave, Tesla, Viking, Nucor, Eli Lilly & more

点「原文对照」整页切到原文,或双击某段只看那段的原文。

以下是周一华尔街的重磅观点:巴克莱重申礼来“增持”评级。巴克莱将礼来目标价从每股1400美元上调至1550美元。“定价仍将是争论焦点,但销量机会不断扩大。重申‘增持’评级及1550美元目标价。”

Here are Monday's biggest calls on Wall Street: Barclays reiterates Eli Lilly as overweight Barclays raised its price target on Eli Lilly to $1,550 per share from $1,400. "Pricing will remain the debate, but the volume opportunity keeps getting bigger.

Canaccord将York Space Systems评级从“持有”上调至“买入”。Canaccord表示该股票估值过低,不容忽视。“York Space Systems(YSS)公布了2026财年第三季度业绩,营收为8420万美元(同比下降7.3%),调整后EBITDA亏损2760万美元。”

Reiterate OW rating and $1,550 PT." Canaccord upgrades York Space Systems to buy from hold Canaccord says the stock is too cheap to ignore. " York Space Systems (YSS) announced Q3/26 results, announcing revenues of $84.2M (down 7.3% y/y) and an Adj. EBITDA loss of ($27.6M)."

Jefferies首次覆盖Yarrow Biosciences,给予“买入”评级。Jefferies表示这家生物技术公司处于有利位置。“我们认为YARW是一家极具吸引力的纯Graves病(甲状腺功能亢进症)药物研发公司……”摩根大通重申特斯拉“中性”评级。摩根大通称对该公司Robotaxi机会的看法更加乐观。“特斯拉近期Robotaxi车队和网约车业务的快速扩张,包括本周末启动的Cybercab客户销售,开始呈现出该公司在实体AI领域独特优势的早期验证,在软件、制造和算力方面实现了深度垂直整合。”

Jefferies initiates Yarrow Biosciences as buy Jefferies said the biotech company is well positioned. "We view YARW as a compelling pure-play Graves' disease company..." JPMorgan reiterates Tesla as neutral JPMorgan said it's getting more constructive on the company's robotaxi opportunity. "TSLA's recent rapid ramp of its robotaxi fleet and ride-hailing operations, including this weekend's launch of customer Cybercab sales, is starting to present early validation of the company's unique advantage in physical AI, with deep vertical integration across software, manufacturing, and compute."

UBS将Peabody Energy评级从“中性”上调至“买入”。UBS表示看到极具吸引力的风险回报比。“

UBS upgrades Peabody Energy to buy from neutral UBS said it sees a compelling risk/reward. "

阅读媒体原文 ↗